{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T23:10:05Z","timestamp":1784675405914,"version":"3.55.0"},"reference-count":25,"publisher":"BMJ","issue":"1","funder":[{"name":"European Charcot Foundation","award":["No award\/grant number."],"award-info":[{"award-number":["No award\/grant number."]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Neurol Neurosurg Psychiatry"],"published-print":{"date-parts":[[2022,1]]},"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>To describe onset clinical features predicting time to first relapse and time to long-term visual, motor and cognitive disabilities in paediatric-onset aquaporin-4 antibody (AQP4-IgG) neuromyelitis optica spectrum disorders (NMOSDs).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>In this retrospective UK multicentre cohort study, we recorded clinical data of paediatric-onset AQP4-IgG NMOSD. Univariate and exploratory multivariable Cox proportional hazard models were used to identify long-term predictors of permanent visual disability, Expanded Disability Status Scale (EDSS) score of 4 and cognitive impairment.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>We included 49 paediatric-onset AQP4-IgG patients (38.8% white, 34.7% black, 20.4% Asians and 6.1% mixed), mean onset age of 12\u00b14.1 years, and 87.7% were female. Multifocal onset presentation occurred in 26.5% of patients, and optic nerve (47%), area postrema\/brainstem (48.9%) and encephalon (28.6%) were the most involved areas. Overall, 52.3% of children had their first relapse within 1 year from disease onset. Children with onset age &lt;12 years were more likely to have an earlier first relapse (p=0.030), despite showing no difference in time to immunosuppression compared with those aged 12\u201318 years at onset. At the cohort median disease duration of 79 months, 34.3% had developed permanent visual disability, 20.7% EDSS score 4 and 25.8% cognitive impairment. Visual disability was associated with white race (p=0.032) and optic neuritis presentations (p=0.002). Cognitive impairment was predicted by cerebral syndrome presentations (p=0.048), particularly if resistant to steroids (p=0.034).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Age at onset, race, onset symptoms and resistance to acute therapy at onset attack predict first relapse and long-term disabilities. The recognition of these predictors may help to power future paediatric clinical trials and to direct early therapeutic decisions in AQP4-IgG NMOSD.<\/jats:p><\/jats:sec>","DOI":"10.1136\/jnnp-2021-327206","type":"journal-article","created":{"date-parts":[[2021,9,28]],"date-time":"2021-09-28T19:45:12Z","timestamp":1632858312000},"page":"101-111","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":30,"title":["Early predictors of disability of paediatric-onset AQP4-IgG-seropositive neuromyelitis optica spectrum disorders"],"prefix":"10.1136","volume":"93","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4925-9000","authenticated-orcid":false,"given":"Valentina","family":"Camera","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1134-5771","authenticated-orcid":false,"given":"Silvia","family":"Messina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kariem Tarek","family":"Elhadd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Sanpera-Iglesias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romina","family":"Mariano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yael","family":"Hacohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2993-585X","authenticated-orcid":false,"given":"Ruth","family":"Dobson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0334-539X","authenticated-orcid":false,"given":"Stefano","family":"Meletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evangeline","family":"Wassmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming J","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saif","family":"Huda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheryl","family":"Hemingway","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Isabel","family":"Leite","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sithara","family":"Ramdas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline","family":"Palace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2021,9,28]]},"reference":[{"key":"2024021904150890000_93.1.101.1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000001729"},{"key":"2024021904150890000_93.1.101.2","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/S0140-6736(04)17551-X","article-title":"A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis","volume":"364","author":"Lennon","year":"2004","journal-title":"The Lancet"},{"key":"2024021904150890000_93.1.101.3","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20050304"},{"key":"2024021904150890000_93.1.101.4","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2014-308550"},{"key":"2024021904150890000_93.1.101.5","doi-asserted-by":"crossref","first-page":"339","DOI":"10.3389\/fped.2020.00339","article-title":"Pediatric NMOSD: a review and position statement on approach to work-up and diagnosis","volume":"8","author":"Tenembaum","year":"2020","journal-title":"Front Pediatr"},{"key":"2024021904150890000_93.1.101.6","doi-asserted-by":"publisher","DOI":"10.1001\/archneurol.2012.249"},{"key":"2024021904150890000_93.1.101.7","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000314832.24682.c6"},{"key":"2024021904150890000_93.1.101.8","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3181f39a66"},{"key":"2024021904150890000_93.1.101.9","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000837"},{"key":"2024021904150890000_93.1.101.10","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e318248dec1"},{"key":"2024021904150890000_93.1.101.11","doi-asserted-by":"publisher","DOI":"10.1017\/S1355617717001060"},{"key":"2024021904150890000_93.1.101.12","unstructured":"Age groups. Available: https:\/\/www.ethnicity-facts-figures.service.gov.uk\/uk-population-by-ethnicity\/demographics\/age-groups\/latest#age-profile-by-ethnicity"},{"key":"2024021904150890000_93.1.101.13","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/aws109"},{"key":"2024021904150890000_93.1.101.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.socscimed.2012.05.018"},{"key":"2024021904150890000_93.1.101.15","doi-asserted-by":"publisher","DOI":"10.1542\/peds.111.1.110"},{"key":"2024021904150890000_93.1.101.16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2005.10.020"},{"key":"2024021904150890000_93.1.101.17","doi-asserted-by":"crossref","first-page":"S46","DOI":"10.1212\/WNL.0000000000002820","article-title":"Pediatric transverse myelitis","volume":"87","author":"Absoud","year":"2016","journal-title":"Neurology"},{"key":"2024021904150890000_93.1.101.18","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1007\/s10792-019-01090-z","article-title":"Plasma exchange: an effective add-on treatment of optic neuritis in neuromyelitis optica spectrum disorders","volume":"39","author":"Song","year":"2019","journal-title":"Int Ophthalmol"},{"key":"2024021904150890000_93.1.101.19","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1055\/s-0036-1578797","article-title":"Plasma exchange and immunoadsorption in pediatric inflammatory optic neuropathy resistant to corticosteroid therapy: four French cases","volume":"47","author":"Jacquet","year":"2016","journal-title":"Neuropediatrics"},{"key":"2024021904150890000_93.1.101.20","doi-asserted-by":"publisher","DOI":"10.1001\/archophthalmol.2012.1126"},{"key":"2024021904150890000_93.1.101.21","doi-asserted-by":"publisher","DOI":"10.1002\/ana.24554"},{"key":"2024021904150890000_93.1.101.22","doi-asserted-by":"crossref","unstructured":"Czarnecka D , Oset M , Karli\u0144ska I , et al . Cognitive impairment in NMOSD\u2014More questions than answers. Brain Behav 2020;10:e01842.doi:10.1002\/brb3.1842","DOI":"10.1002\/brb3.1842"},{"key":"2024021904150890000_93.1.101.23","doi-asserted-by":"publisher","DOI":"10.1002\/ana.23721"},{"key":"2024021904150890000_93.1.101.24","doi-asserted-by":"publisher","DOI":"10.1002\/ana.26067"},{"key":"2024021904150890000_93.1.101.25","doi-asserted-by":"crossref","first-page":"e1299","DOI":"10.1212\/WNL.0000000000008160","article-title":"Serum GFAP and neurofilament light as biomarkers of disease activity and disability in NMOSD","volume":"93","author":"Watanabe","year":"2019","journal-title":"Neurology"}],"container-title":["Journal of Neurology, Neurosurgery &amp; Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jnnp-2021-327206","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,19]],"date-time":"2024-02-19T12:15:31Z","timestamp":1708344931000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnnp.bmj.com\/lookup\/doi\/10.1136\/jnnp-2021-327206"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,28]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12,14]]},"published-print":{"date-parts":[[2022,1]]}},"alternative-id":["10.1136\/jnnp-2021-327206"],"URL":"https:\/\/doi.org\/10.1136\/jnnp-2021-327206","relation":{},"ISSN":["0022-3050","1468-330X"],"issn-type":[{"value":"0022-3050","type":"print"},{"value":"1468-330X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,28]]}}}